Cell Transplant and Regenerative Medicine Society
Camillo Ricordi, USA
Dr. Ricordi is a renowned diabetes researcher based in Miami, Florida. Since 1996, he has served as Director of the Diabetes Research Institute (DRI) at the University of Miami, where he is also Chief Academic Officer and Director of the DRI’s Cell Transplant Center.
Ricordi specializes in pancreatic islet transplantation and has significantly contribute to stem cell research for Type 1 Diabetes treatment. He is credited with developing the “Ricordi Method” for islet cell isolation. His prolific career includes over 1,779 scientific publications, 28 patents, and numerous awards, including the Outstanding Scientific Achievement Award from the American Diabetes Association.
Mission
Our mission is to lead the development and delivery of safe, innovative cellular and regenerative therapies to improve patient’s health. We bring together a global community of experts in the field, thus creating a robust platform for scientific advancement.
Our extensive network supports and promotes collaborative research, educational initiatives, and exchange opportunities among scientists and clinicians from academia and industry. We are dedicated to facilitating the clinical translation of pioneering therapies and addressing the complex regulatory issues that accompany these advancements.
Objectives
- Foster research and collaboration
- Define and disseminate standards
- Advance basic and applied research
- Navigate regulatory aspects
- Educational initiatives
- Support career development